COMP <GO>
UFPT vs LLY // RETURN ON INVESTED CAPITAL (ROIC)
UFP Technologies Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: UFPT 2
— LLY 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LLY
LAST: $293.30 (+2.55%) • MKT CAP: $2.27B
roic
13.90%
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
roic
32.36%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UFPT VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UFPT | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.30% | 83.64% | -55.34 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 13.90% | 32.36% | -18.46 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.7x | 36.4x | -10.72 | UFPT | /valuation <GO> |
| Free Cash Flow Yield | 4.05% | 2.30% | +1.75 | UFPT | /fcf-yield <GO> |
| Operating Margin | 15.30% | 40.21% | -24.91 | LLY | /operating-margins <GO> |
| Net Profit Margin | 11.30% | 31.90% | -20.60 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 19.50% | 45.51% | -26.01 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.31 | 9.29 | -0.98 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.0 | 66.6 | -22.56 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 26.3x | +1.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.27B | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UFPT REV | LLY REV | UFPT GROSS % | LLY GROSS % | UFPT FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $602.8M | $65.18B | 28.3% | 83.0% | $91.9M | $16.81B |
| FY 2024 | $504.4M | $45.04B | 29.1% | 81.3% | $56.9M | $8.82B |
| FY 2023 | $400.1M | $34.12B | — | 79.3% | $41.3M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UFPT // BETA —
LLY // BETA 0.51